Furthermore, hepatic metabolic dysfunction upregulates ALT activity, sustaining inappropriate gluconeogenesis; in this state, insulin fails to suppress hepatic gluconeogenesis effectively, exacerbating insulin resistance and inducing hyperglycemia and hyperinsulinemia (50, 51). The gene discussed is INS; the disease is Insulin resistance.